Newsmeme!
Discover News you didn't know existed
Adjuvant Therapy
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Over-expression and Mutation of a Tyrosine Kinase Receptor FGFR4 in Tumors
Published July 1, 2009, 11:06 am, Pharmalicencing
Identification of mutations in fibroblast growth factor receptor 4 (FGFR4) that are associated with Rhabdomyosarcoma tumors; may be used to identify candidates for treatment with an FGFR4 inhibitor as an adjuvant to standard anticancer therapy.
ABRAXANE Approved For Advanced Breast Cancer Patient Treatment In Quebec
Published July 1, 2009, 6:24 am, Medical News Today
Abraxis BioScience, Inc. (NASDAQ:ABII), an integrated biotechnology company, announced the listing of ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) 100 mg in Quebec for the treatment of metastatic breast cancer with a recommendation from the Quebec Conseil du Médicament and approval from the Quebec Ministry of Health.
Personalized Anti-Cancer Vaccine, BiovaxID(R), Targeting B-Cell Lymphomas Available In Europe On A Named-Patient Basis
Published June 30, 2009, 6:08 am, Medical News Today
Biovest International, Inc. (Other OTC:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (Other OTC:ABPIQ), today announced that BiovaxID®, Biovest's personalized therapeutic anti-cancer vaccine, is available on a named-patient (compassionate-use) basis in Europe.
SciClone Pharmaceuticals, Inc. Added to Russell 3000(R) Index
Published June 30, 2009, 3:04 am, Marketwire
FOSTER CITY, CA--(Marketwire - June 30, 2009) - SciClone Pharmaceuticals, Inc. ( NASDAQ : SCLN ) today announced that it has been added to the Russell 2000® and Russell 3000 Indexes. The Russell 3000 Index measures the performance of the largest 3000 U.S. companies and is a combination of the Russell 1000® and Russell 2000 Indexes. The Russell 2000 Index is a subset of the Russell 3000 Index, ...
TapImmune Announces Corporate Restructuring
Published June 29, 2009, 2:18 pm, Marketwire
BELLEVUE, WA--(Marketwire - June 29, 2009) - TapImmune Inc. ( OTCBB : TPIM ), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announces the appointment of Dr. Glynn Wilson as TapImmune's new Executive Chairman as part of an overall corporate restructuring plan. Dr. Wilson succeeds Alan Lindsay whom TapImmune Inc. ...
Dr. N. Joseph Espat Presented Positive Clinical Results on the Use of Biologics for Abdominal Wall Reconstruction in ...
Published June 29, 2009, 5:30 am, Business Wire via Yahoo! Finance
BLOOMINGTON, Ind.----Dr. N. Joseph Espat M.D., M.S., FACS presented favorable results of biologic materials, specifically Cook Medical's Biodesign™, for the treatment of abdominal wall wounds complicated from chemotherapy, at the Abdominal Wall Reconstruction Conference at the Georgetown University Hospital in Washington, D.C.
ABRAXANE Approved for Advanced Breast Cancer Patient Treatment in Quebec
Published June 29, 2009, 5:05 am, Business Wire via Yahoo! Finance
LOS ANGELES & TORONTO----Abraxis BioScience, Inc. , an integrated biotechnology company, today announced the listing of ABRAXANE® for Injectable Suspension 100 mg in Quebec for the treatment of metastatic breast cancer with a recommendation from the Quebec Conseil du Medicament and approval from the Quebec Ministry of Health.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |